Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atypical prostatic stromal lesions.

M B Cohen1

  • 1Department of Pathology, University of Iowa, Iowa City, USA.

Advances in Anatomic Pathology
|March 30, 1999
PubMed
Summary
This summary is machine-generated.

This commentary reviews new classifications for rare prostate stromal lesions. Prostatic stromal proliferation of uncertain malignant potential appears benign, while prostatic stromal sarcoma may be malignant with unclear differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active Precipitation of Radiation Belt Electrons Using Rocket Exhaust Driven Amplification (REDA) of Man-Made Whistlers.

Journal of geophysical research. Space physics·2022
Same author

Induction of cytochrome P450-mediated detoxification of xanthotoxin in the black swallowtail.

Journal of chemical ecology·2013
Same author

Histamine azoprotein in the treatment of allergy.

The Journal of allergy·2010
Same author

The effect of beta-dimethylaminoethyl-benzhydryl-ether-hydrochloride on the histamine threshold of human skin.

The Journal of allergy·2010
Same author

Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.

American journal of physiology. Gastrointestinal and liver physiology·2009
Same author

Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.

Investigational new drugs·2007
Same journal

An Update on Soft Tissue Tumors of the Paratesticular Region.

Advances in anatomic pathology·2026
Same journal

Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

Advances in anatomic pathology·2026
Same journal

Hereditary and Familial Tumor Syndromes: When to Think of Them? The Emerging Role of Pathologists as Sentinels of Genetic Cancer Predisposition.

Advances in anatomic pathology·2026
Same journal

From Familial Clustering to a Dedicated Classification: The Historical Recognition of Hereditary Tumor Syndromes in the WHO Classification of Tumors.

Advances in anatomic pathology·2026
Same journal

The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes.

Advances in anatomic pathology·2026
Same journal

DICER1 Syndrome and Tumor Pathology: An Updated Review for Diagnostic Practice.

Advances in anatomic pathology·2026
See all related articles

Area of Science:

  • Uropathology
  • Oncology
  • Histopathology

Background:

  • Rare atypical stromal lesions of the prostate require precise classification.
  • Existing classifications may not fully capture the behavior of these entities.
  • Understanding the behavior of prostatic stromal lesions is crucial for patient management.

Purpose of the Study:

  • To address the newly proposed classification of rare atypical prostatic stromal lesions.
  • To clarify the behavior and potential malignancy of these entities.
  • To discuss the implications of the new classification in clinical practice.

Main Methods:

  • Review of current literature and proposed classifications.
  • Analysis of histopathological features.
  • Discussion of clinical behavior and prognostic indicators.

Related Experiment Videos

Main Results:

  • The entity "prostatic stromal proliferation of uncertain malignant potential" demonstrates benign behavior.
  • The entity "prostatic stromal sarcoma" may possess malignant potential.
  • The exact line of differentiation for prostatic stromal sarcoma remains unclear.

Conclusions:

  • The proposed classification offers a framework for understanding these rare lesions.
  • Distinguishing between benign and potentially malignant stromal lesions is critical.
  • Further research is needed to clarify the differentiation of prostatic stromal sarcoma.